首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Pharmaceutical statistics

缩写:PHARM STAT

ISSN:1539-1604

e-ISSN:1539-1612

IF/分区:1.4/Q2

文章目录 更多期刊信息

共收录本刊相关文章索引1174
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Sunita Rehal,Nicky Best,Sarah Watts et al. Sunita Rehal et al.
The estimand framework proposes different strategies to address intercurrent events. The treatment policy strategy seems to be the most favoured as it is closely aligned with the pre-addendum intention-to-treat principle. All data for all p...
Zhanfeng Wang,Zerui Shen,Ruixing Ming et al. Zhanfeng Wang et al.
Motivated by the analysis of data from a clinical trial on patients with early breast cancer, we propose in this paper a new joint model that uses a Tobit partly linear mixed model for longitudinal measurements which are bounded in an inter...
Meike Adani,Silvia Noirjean,Andrea Callegaro et al. Meike Adani et al.
During a vaccine development program, if the assay used to measure immunological endpoints is changed, ideally, a bridging study is performed to establish the relationship between results obtained with the new and previous assay. However, t...
Sören Budig,Charlotte Vogel,Frank Schaarschmidt Sören Budig
Overdispersion, a common issue in clustered multinomial data, can lead to biased standard errors and compromised statistical inference if not adequately addressed. This study describes a comprehensive procedure for constructing multiple com...
Dario Zocholl,Heiko Götte,Christina Habermehl et al. Dario Zocholl et al.
The conduct of dose-finding trials can be specifically challenging in small populations, for example, in pediatric settings. Recently, research has shown that Bayesian borrowing from adult trials combined with appropriately robust prior dis...
Dominic Magirr,Fredrik Öhrn Dominic Magirr
The introduction of checkpoint inhibitors in immuno-oncology has raised questions about the suitability of the log-rank test as the default primary analysis method in confirmatory studies, particularly when survival curves exhibit non-propo...
Seok-Jae Heo,Inkyung Jung Seok-Jae Heo
The concomitant use of multiple drugs increases the risk of adverse events (AEs) due to drug-drug interactions (DDIs), which remain challenging to identify since clinical trials primarily focus on individual drugs, necessitating postmarket ...
Shuqi Wang,Yunqi Zhao,Jia Li et al. Shuqi Wang et al.
In cell therapy product development, cell expansion is highly correlated with response and safety. Significant heterogeneity in patient and product characteristics contributes to variability in cell expansion, persistence and response. Inte...
Saurabh Mukhopadhyay,Yujie Zhao,Xiaotian Chen et al. Saurabh Mukhopadhyay et al.
In clinical research, it is increasingly difficult to conduct fully powered and well-balanced randomized controlled trials, particularly when studying rare or devastating diseases and pediatric patients. While Bayesian methodologies are ver...
Daniel J Bratton Daniel J Bratton
Quantitative decision-making frameworks provide objective criteria for advancing a drug development program. Within this process, two types of decision error can occur: proceeding to the next phase and failing (incorrect go) or not proceedi...